Here's What the Surge in COVID's Delta Variant Could Mean for Pfizer's Stock

Here's What the Surge in COVID's Delta Variant Could Mean for Pfizer's Stock

Despite the proliferation of effective vaccines in some parts of the world, coronavirus infections are still rising around the globe. In the U.S., the surging delta variant of the virus is responsible for a whopping 83% of new cases. While it seems that it's mostly unvaccinated people who are getting seriously ill, the unfortunate fact of the matter is that the delta variant is putting the vaccines to the test.